Bayer: US Supreme Court ruling should result in dismissal of current warning-based claims
Bayer: US Supreme Court ruling should result in dismissal of current warning-based claims BERLIN, June 25 (Reuters) - A U.S. Supreme Court ruling that scales back Roundup cancer lawsuits and which sent Bayer shares up 18% should result in the dismissal of current warning-based claims and bar future failure-to-warn claims, the company said on Thursday.
"The U.S. Supreme Court decision is good for science, farmers, and industries that depend on regulatory clarity for innovation. It should help significantly contain the Roundup litigation after nearly a decade of legal battles," the company said in a statement.
(Writing by Madeline Chambers, Editing by Friederike Heine)
((Madeline.Chambers@thomsonreuters.com; +4930220133578;))
Recent news on Bayer AG
See all newsBayer takes a giant leap toward investability
Europe Research Roundup: Barratt Redrow, Ferrari, KPN
Explainer: What does Bayer's US Supreme Court win mean for the thousands of Roundup lawsuits?
Bayer shares soar over 18% after U.S. Supreme Court curbs Roundup lawsuits
US Supreme Court scales back Roundup cancer suits in win for Bayer (updated)